Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-07-11

Clinical Trial Update: Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma [NA]

View source ↗

Summary

The clinical trial assessing whether glutamine prevents oral mucositis in patients receiving chemotherapy for sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutamine (glutamine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma | NA | Status: WITHDRAWN